hashimoto disease and semaglutide Can a patient with Hashimoto's thyroiditis safely be treated with a GLP‑1 receptor agonist (e.g., liraglutide, semaglutide, dulaglutide)? ⚠️There is no evidence to

GLP-1 medications can dramatically improve weight loss and blood sugar management, but consistency is what turns a prescription into real results

Common side effects include gastrointestinal symptoms, with berberine potentially interacting with diabetes medications and drugs metabolised by CYP enzymes

[1] [2] Crucially, this effect is glucose-dependent, meaning insulin release only occurs when blood glucose levels are elevated, which significantly reduces the risk of hypoglycaemia compared to sulfonylureas or insulin therapy, though this risk remains if Ozempic is combined with these medications

Mielants H, De Vos M, Goemaere S et al (1991) Intestinal mucosal permeability in inflammatory rheumatic diseases